An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

NCT01286090 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor request

Conditions

Gastroparesis
Diabetes Mellitus

Interventions

DRUG: Cisapride
DRUG: Placebo

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.